Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.6100 (-5.58%) ($7.5800 - $7.9700) on Mon. May. 13, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.17% (three month average) | RSI | 41 | Latest Price | $7.6100(-5.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UUP(6%) XLC(4%) BLOK(2%) TBT(2%) VXX(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.585% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.585% (StdDev 3.17%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
Resistance Level | $7.84 | 5 Day Moving Average | $7.8(-2.44%) | 10 Day Moving Average | $7.71(-1.3%) | 20 Day Moving Average | $7.84(-2.93%) | To recent high | -16.8% | To recent low | 4.5% | Market Cap | $1.343b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |